"My doctor was like, I dont know what the problem is, Im not seeing this in other people.
Semaglutide is a GLP-1 receptor agonist that works on your appetite, insulin response, and inflammation pathways
However, a subsequent analysis using a large, nationally representative dataset found no significant association between glucagon-like peptide-1 receptor agonist (GLP-1RA) drugs, including semaglutide, and NAION after controlling for confounding factors
In 2.1 years of median follow-up, semaglutide initiators had a 2.33-fold higher risk than comparator patients (hazard ratio, 2.33
The principle is that two smaller doses may produce more stable blood levels and fewer peak-related side effects
Revenues from pharmaceutical and biotech companies, device manufacturers and health insurance providers and the Associations overall financial information are available here